Can We Improve the Statistical Analysis of Stroke Trials? Statistical Reanalysis of Functional Outcomes in Stroke Trials
ثبت نشده
چکیده
Background and Purpose—Most large acute stroke trials have been neutral. Functional outcome is usually analyzed using a yes or no answer, eg, death or dependency versus independence. We assessed which statistical approaches are most efficient in analyzing outcomes from stroke trials. Methods—Individual patient data from acute, rehabilitation and stroke unit trials studying the effects of interventions which alter functional outcome were assessed. Outcomes included modified Rankin Scale, Barthel Index, and “3 questions”. Data were analyzed using a variety of approaches which compare 2 treatment groups. The results for each statistical test for each trial were then compared. Results—Data from 55 datasets were obtained (47 trials, 54 173 patients). The test results differed substantially so that approaches which use the ordered nature of functional outcome data (ordinal logistic regression, t test, robust ranks test, bootstrapping the difference in mean rank) were more efficient statistically than those which collapse the data into 2 groups ( ; ANOVA, P 0.001). The findings were consistent across different types and sizes of trial and for the different measures of functional outcome. Conclusions—When analyzing functional outcome from stroke trials, statistical tests which use the original ordered data are more efficient and more likely to yield reliable results. Suitable approaches included ordinal logistic regression, t test, and robust ranks test. (Stroke. 2007;38:1911-1915.)
منابع مشابه
Can we improve the statistical analysis of stroke trials? Statistical reanalysis of functional outcomes in stroke trials.
BACKGROUND AND PURPOSE Most large acute stroke trials have been neutral. Functional outcome is usually analyzed using a yes or no answer, eg, death or dependency versus independence. We assessed which statistical approaches are most efficient in analyzing outcomes from stroke trials. METHODS Individual patient data from acute, rehabilitation and stroke unit trials studying the effects of inte...
متن کاملOptimising Analysis of Stroke Trials Collaboration, OAST (2007) Can we improve the statistical analysis of stroke trials? Statistical reanalysis of functional outcomes in stroke
The Nottingham ePrints service makes this work by researchers of the University of Nottingham available open access under the following conditions. A note on versions: The version presented here may differ from the published version or from the version of record. If you wish to cite this item you are advised to consult the publisher's version. Please see the repository url above for details on ...
متن کاملشاک ویودرمانی برای کاهش اسپاستیسیتی پس از سکته مغزی: مقاله مروری و متاآنالیز
Background: Spasticity is a clinical deficit of upper motor neurons lesions that presented immediately or at delayed times after lesions and occurs in about 38% of stroke patients. Extracorporeal shock wave therapy (ESWT) has been recently reported as a safe and effective method for reducing spasticity in stroke patients. In the present study, we sought to investigate the impact of the ESWT on ...
متن کاملShould stroke trials adjust functional outcome for baseline prognostic factors?
BACKGROUND AND PURPOSE Many stroke trials have provided neutral results. Suboptimal statistical analyses may be failing to detect effective interventions. Adjusting outcomes for baseline prognostic factors in the analysis may improve the efficiency of analysis of outcomes. METHODS Data from 23 stroke trials (25 674 patients) assessing functional outcome were included. The prognostic variables...
متن کاملTargeting neuroprotection clinical trials to ischemic stroke patients with potential to benefit from therapy.
BACKGROUND AND PURPOSE Clinical trials of neuroprotective drugs have had limited success. We investigated whether selecting patients according to prognostic features would improve the statistical power of a trial to identify an efficacious treatment. METHODS Using placebo data from the Glycine Antagonist in Neuroprotection (GAIN) International and National Institute of Neurological Disorders ...
متن کامل